These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 396066)
1. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin. Fagard R; Amery A; Lijnen P; Reybrouck T Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor. Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956 [TBL] [Abstract][Full Text] [Related]
3. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes. Mookherjee S; Obeid A; Warner R; Anderson G; Eich R; Smulyan H Am J Cardiol; 1978 Dec; 42(6):987-92. PubMed ID: 727149 [TBL] [Abstract][Full Text] [Related]
4. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats. Kaukinen S; Kataja J; Ylitalo P Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of captopril and saralasin in essential and renal hypertension. Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597 [TBL] [Abstract][Full Text] [Related]
6. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
7. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients. Hashimoto H; Hiwada K; Kokubu T Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543 [TBL] [Abstract][Full Text] [Related]
9. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients. Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392 [No Abstract] [Full Text] [Related]
10. Does the renin-angiotensin system maintain blood pressure in both hypertensive and normotensive subjects? A comparison of propranolol, saralasin and captopril. MacGregor GA; Markandu ND; Roulston JE Clin Sci (Lond); 1979 Dec; 57 Suppl 5():145s-148s. PubMed ID: 396068 [No Abstract] [Full Text] [Related]
12. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure. Packer M; Lee WH; Medina N; Yushak M J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397 [TBL] [Abstract][Full Text] [Related]
13. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin. Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855 [TBL] [Abstract][Full Text] [Related]
14. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats. Hutchinson JS; Mendelsohn FA; Doyle AE Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407 [TBL] [Abstract][Full Text] [Related]
15. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril. Zawada ET; Stinson J; Ramirez G Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479 [TBL] [Abstract][Full Text] [Related]
16. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril. Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A Acta Cardiol; 1982; 37(1):1-9. PubMed ID: 6282024 [TBL] [Abstract][Full Text] [Related]
17. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension. Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874 [TBL] [Abstract][Full Text] [Related]
18. Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension. Koletsky RJ; Gordon MB; LeBoff MS; Moore TJ; Dluhy RG; Hollenberg NK; Williams GH Clin Sci (Lond); 1984 Mar; 66(3):299-305. PubMed ID: 6362960 [TBL] [Abstract][Full Text] [Related]
19. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects. Sharpe DN; Coxon R Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746 [TBL] [Abstract][Full Text] [Related]
20. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]